Active Ingredient History
APREMILAST, (±)- is a mixture of isomers, one of them is therapeutic active S form (apremilast), an inhibitor of phosphodiesterase 4. This active form is sold under the brand name OTEZLA for the treatment of adult patients with active psoriatic arthritis. NCATS
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Acne Conglobata (Phase 2)
Acne Vulgaris (Phase 2)
Alcoholism (Phase 2)
Alopecia (Phase 4)
Arthritis, Rheumatoid (Phase 2)
Behcet Syndrome (Phase 3)
Cardiovascular Diseases (Phase 4)
Colitis, Ulcerative (Phase 2)
COVID-19 (Phase 3)
Dermatitis, Allergic Contact (Phase 2)
Dermatitis, Atopic (Phase 2)
Dermatology (Phase 2)
Dermatomyositis (Phase 2)
Digital Dermatitis (Phase 4)
Eczema (Phase 2)
Erythema (Phase 4)
Genital Diseases, Female (Phase 2)
Gout (Phase 2)
Healthy Volunteers (Phase 1)
Hidradenitis Suppurativa (Phase 2)
Lichen Planus (Phase 2)
Lichen Planus, Oral (Phase 2)
Lupus Erythematosus, Discoid (Phase 1/Phase 2)
Osteoarthritis (Phase 2)
Parapsoriasis (Phase 4)
Pharmacokinetics (Phase 1)
Prostatitis (Phase 2)
Prurigo (Phase 2)
Pruritus (Phase 2)
Psoriasis ()
Rosacea (Phase 2)
Sarcoidosis (Phase 2/Phase 3)
Spondylitis, Ankylosing (Phase 3)
Stomatitis, Aphthous (Phase 3)
Substance Withdrawal Syndrome (Phase 3)
Uveitis (Phase 1/Phase 2)
Vitiligo (Phase 2)
Vulva (Phase 2)
Vulvodynia (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue